Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: J Neuropathol Exp Neurol. 2015 May;74(5):442–452. doi: 10.1097/NEN.0000000000000188

Figure 2.

Figure 2

Effect of CDKN2A loss on overall survival of histologically classified lower grade (World Health Organization II-III) gliomas. (A–D) CDKN2A loss was associated with worse overall survival in lower grade gliomas not stratified by histology (A) and in astrocytomas (B), but not in oligodendrogliomas (C) or oligoastrocytomas (D).